$RGLS Regulus Therapeutics Inc. Insider Trading Week 42/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Regulus Therapeutics Inc. in week 42/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 15.19 | 1,850 | 28,109 | 6,795,716 | 6.8 M to 6.8 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 14.24 | 1,700 | 24,202 | 6,797,566 | 6.8 M to 6.8 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 14.00 | 109,534 | 1,533,125 | 6,799,266 | 6.9 M to 6.8 M (-1.59 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 15.19 | 1,850 | 28,109 | 5,896,716 | 5.9 M to 5.9 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.24 | 1,700 | 24,202 | 5,898,566 | 5.9 M to 5.9 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.00 | 109,534 | 1,533,125 | 5,900,266 | 6 M to 5.9 M (-1.82 %) |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | Szekeres David Leslie | CBO and General Cou ... | Option Exercise | A | 8.51 | 40,000 | 340,400 | 40,000 | |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 6.13 | 40,000 | 245,200 | 40,000 | |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 3,300 | 5,742 | 116,500 | |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 14.44 | 3,300 | 47,644 | 80,000 | 83.3 K to 80 K (-3.96 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 3,300 | 5,742 | 83,300 | 80 K to 83.3 K (+4.13 %) |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | Chief Medical Offic ... | Option Exercise | A | 7.58 | 40,000 | 303,200 | 40,000 | |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | A | 6.13 | 88,000 | 539,440 | 88,000 | |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 300 | 114 | 451,792 | |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 400 | 152 | 452,092 | |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 300 | 2,100 | 2,466 | 2.8 K to 2.5 K (-10.85 %) |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 300 | 114 | 2,766 | 2.5 K to 2.8 K (+12.17 %) |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.04 | 400 | 2,816 | 2,466 | 2.9 K to 2.5 K (-13.96 %) |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 400 | 152 | 2,866 | 2.5 K to 2.9 K (+16.22 %) |